Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil add-on to bosentan in pulmonary arterial hypertension
2006-001464-23Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing Revatio + bosentan with Placebo + bosentan (2 arms). Started Apr 2006; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2006-001464-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001464-23.